DFTX (DFTX)
23.55
-1.04 (4.23%)
Upcoming Events
Latest Headlines
Definium Therapeutics Announces New Employee Inducement Grants
June 1, 2026 4:01 PM - BizWire
Definium Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
May 21, 2026 7:00 AM - BizWire
Form 8-K Definium Therapeutics, For: May 19
May 19, 2026 7:31 AM - SEC Filing
Form SCHEDULE 13G/A Definium Therapeutics, Filed by: Deep Track Capital, LP
May 15, 2026 9:15 AM - SEC Filing
Form 8-K Definium Therapeutics, For: May 12
May 12, 2026 8:15 AM - SEC Filing
Definium begins second phase 3 trial of DT120 for depression
May 12, 2026 7:00 AM - StreetInsider
Definium begins second phase 3 study of DT120 for depression
May 12, 2026 7:00 AM - StreetInsider
Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 ODT in Major Depressive Disorder
May 12, 2026 7:00 AM - BizWire
Definium Therapeutics Announces New Employee Inducement Grants
May 11, 2026 4:01 PM - BizWire
Definium Therapeutics Inc (DFTX) PT Lowered to $48 at Piper Sandler
May 8, 2026 7:57 AM - StreetInsider
RBC Capital Reiterates Outperform Rating on Definium Therapeutics Inc (DFTX), sees favorable set up
May 8, 2026 6:32 AM - StreetInsider
Definium Therapeutics, Inc. (DFTX) Misses Q1 EPS by 23c
May 7, 2026 4:20 PM - StreetInsider
Form 10-Q Definium Therapeutics, For: Mar 31
May 7, 2026 4:20 PM - SEC Filing
Form 8-K Definium Therapeutics, For: May 07
May 7, 2026 4:14 PM - SEC Filing
Definium Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
May 7, 2026 4:01 PM - BizWire
Definium Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026
April 30, 2026 4:01 PM - BizWire
Form DEFA14A Definium Therapeutics,
April 27, 2026 4:08 PM - SEC Filing
Form DEF 14A Definium Therapeutics, For: Jun 11
April 27, 2026 4:06 PM - SEC Filing
Definium Therapeutics (DFTX) Reiterated at Buy by Stifel After Analyst Day
April 24, 2026 8:03 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Definium Therapeutics Inc (DFTX)
April 24, 2026 6:41 AM - StreetInsider
Piper Sandler Reiterates Overweight Rating on Definium Therapeutics Inc (DFTX)
April 23, 2026 9:15 AM - StreetInsider
Definium Therapeutics Inc (DFTX) PT Raised to $40 at Oppenheimer
April 23, 2026 8:22 AM - StreetInsider
Form 8-K Definium Therapeutics, For: Apr 22
April 22, 2026 4:24 PM - SEC Filing
Definium Therapeutics updates DT120 clinical trials and commercial plans
April 22, 2026 4:15 PM - StreetInsider
Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day
April 22, 2026 4:15 PM - BizWire
Definium Therapeutics Announces New Employee Inducement Grants
April 20, 2026 4:01 PM - BizWire
Psychedelic drug developers rally after Trump orders FDA to expedite reviews
April 20, 2026 6:43 AM - StreetInsider
Psychedelic stocks soar after Trump signs executive order to fast-track treatments
April 20, 2026 6:08 AM - StreetInsider
Definium Therapeutics Applauds White House Executive Order to Accelerate Mental Health Innovation and Expand Access to Psychedelic Medical Treatments
April 18, 2026 7:38 PM - BizWire
Stifel Starts Definium Therapeutics Inc (DFTX) at Buy
April 16, 2026 4:07 PM - StreetInsider
White House Prepares Order On Ibogaine Psychedelic - CBS
April 16, 2026 11:53 AM - StreetInsider
Definium Therapeutics Inc (DFTX) PT Raised to $38 at Canaccord
April 16, 2026 6:59 AM - StreetInsider
Piper Sandler Starts Definium Therapeutics Inc (DFTX) at Overweight
April 10, 2026 1:54 AM - StreetInsider
Definium Therapeutics to Participate at Upcoming Investor Conferences and Events
April 9, 2026 7:00 AM - BizWire
Definium study shows anxiety disorder prevalence rose to 6.6% in 2023
March 31, 2026 7:01 AM - StreetInsider
New Definium Therapeutics Study Published in the Journal of Mood and Anxiety Disorders Reveals Increasing Prevalence and Burden of Generalized Anxiety Disorder in the United States
March 31, 2026 7:00 AM - BizWire
Definium Therapeutics Announces New Employee Inducement Grants
March 30, 2026 4:01 PM - BizWire
Form 4 Definium Therapeutics, For: Mar 25 Filed by: Karlin Daniel
March 26, 2026 6:43 PM - SEC Filing
Form 4 Definium Therapeutics, For: Mar 25 Filed by: Sullivan Mark
March 26, 2026 6:43 PM - SEC Filing
Form 4 Definium Therapeutics, For: Mar 25 Filed by: Barrow Robert
March 26, 2026 6:42 PM - SEC Filing
Definium Therapeutics to Host Investor and Analyst Day in New York on April 22, 2026
March 26, 2026 7:00 AM - BizWire
Form 144 Definium Therapeutics, Filed by: Barrow Robert
March 25, 2026 5:41 PM - SEC Filing
Form 144 Definium Therapeutics, Filed by: Karlin Daniel
March 25, 2026 5:41 PM - SEC Filing
Form 144 Definium Therapeutics, Filed by: Sullivan Mark
March 25, 2026 5:40 PM - SEC Filing
Definium Therapeutics Announces New Employee Inducement Grants
March 9, 2026 4:01 PM - BizWire
Full Article List
